Guardian Pharmacy Services, Inc. earnings releases GRDN

Guardian Pharmacy Services, Inc. last reported quarterly results on Nov 5, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $371.1 million (-1.7% year over year) and diluted EPS of $0.29. It usually reports 13–37 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 12, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 13–37 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Nov 5, 2026
36 days after quarter end
Q3 FY2026
ended Sep 30, 2026
371
-1.7%
19
+90.3%
0.29
Aug 6, 2026
37 days after quarter end
Q2 FY2026
ended Jun 30, 2026
352
+2.2%
22
+142.2%
—
May 6, 2026
36 days after quarter end
Q1 FY2026
ended Mar 31, 2026
337
+2.2%
13
+40.7%
—
Jan 13, 2026
13 days after quarter end
Q4 FY2025
ended Dec 31, 2025
398
21
—
Nov 10, 2025
41 days after quarter end
Q3 FY2025
ended Sep 30, 2025
377
+20.0%
10
+108.0%
—
Aug 11, 2025
42 days after quarter end
Q2 FY2025
ended Jun 30, 2025
344
9
—
May 12, 2025
42 days after quarter end
Q1 FY2025
ended Mar 31, 2025
329
9
—
Mar 3, 2025
62 days after quarter end
Q4 FY2024
ended Dec 31, 2024
—
—
—

Company profile

Industry
Retail-Drug Stores and Proprietary Stores (SIC 5912)
Listed as
GRDN (NYSE)
Fiscal year ends
December 31
Incorporated in
GA
Headquarters
Atlanta, GA
SEC filer status
Accelerated filer
SEC CIK
1802255
Former names
Guardian Pharmacy Services, Inc. (until Nov 5, 2026); Guardian Pharmacy, LLC (until Jul 23, 2021)

Other Retail-Drug Stores and Proprietary Stores companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.